|CCMG Website monthly update – Fall 2018|
As we come to the end of 2018, it is an opportunity to look back on the success of the CCMG over the past year and reflect on how the College can continue to improve in 2019.
As you know, the CCMG Board had sent a strategic directions survey to the membership in September to capture the input of CCMG members on what the CCMG Board and the College has done well, and what we can improve going forward. The input from the 76 respondents (representing 25% of the total CCMG membership) provided excellent input and suggestions for the CCMG Board to consider in shaping our initiatives over the next year.
In particular, the respondents indicated that the top three priorities that the CCMG should focus on over the next few years were, in order of highest importance:
Other themes from the survey results were the importance of the new CCMG initiative in providing a merged cytogenetic-molecular laboratory training program, a desire for more educational activities and including enhanced training in molecular pathology, and increasing the CCMG collaboration with other national organizations. The CCMG Board is using the results of the strategy survey to help inform decisions as we plan for new CCMG activities in 2019, and we greatly appreciate all of the very useful information that was provided.
Related to the new initiative on the merger of the cytogenetics-molecular genetics laboratory training program (as approved by the CCMG membership at the AGM in June 2018), the group now known as the Genetic and Genomic Diagnostics (GGD) Training Program Working Group has officially been established and is actively meeting via teleconference. As discussed at the 2018 AGM, and in the Terms of Reference posted on the CCMG website, the planned started date of the first trainees to begin the merged GGD training is July 2020. Please find more information at this link.
I am also very happy to announce that Dr. Isabelle De Bie has agreed to take on the role of President-Elect for the CCMG. Isabelle will remain in this role until 2020, when she will take over as President at the June 2020 AGM. I would also like to personally welcome the new CCMG committee members who will officially join their respective committees on January 1, 2019. The committee list of the website has been updated to reflect the new membership. Thank you to all!
In closing, I would like to thank the Board, committee chairs and members who dedicate their time to carrying out the work our College. I hope you all have a relaxing holiday season, and look forward to our continued work together in 2019,
With best wishes,
|Fellows Who Recently Passed Exams|
The CCMG had a very successful exam cycle this year, with 29 trainees passing their respective CCMG exams. The final credentials review of 28 new CCMG Fellows who submitted their documents was completed in November. A huge thank Dr. Mary Shago and the members of the CCMG Credentials committee for their ongoing work in reviewing the trainees’ applications for fellowships. The new members have now been posted on the CCMG website, so please have a look and congratulate your new colleagues on their achievements!
|Tips & Tricks for Category 3 Credits in the RCPSC Maintenance of Certification Program|
You have likely all recently received a reminder from the RCPSC Maintenance of Certification (MOC) program to record your activities for 2018. If you would like to find out more ways to obtain MOC ‘Category 3’ credits, the CCMG E2P2 committee recently worked with the RCPSC MOC program to define some ‘tips and tricks’ on how to obtain credits in Category 3.
|Update on the Genetic & Genomic Diagnostics (GGD) Training Working Group|
As you know at the 2018 AGM in Harrison Hot Springs the CCMG membership voted to endorse recommendations that the CCMG should create a merged laboratory Genetic and Genomic Diagnostics (GGD) training program, to incorporate the former Molecular Genetics and Cytogenetics training programs. The merged training would be designed to be completed in a minimum of 2 years of full time activity and with a single certifying exam, and with a planned implementation date of the merged training start in July 2020.
The Terms of Reference for the GGD Working Group were approved in July, and after a call for volunteers in September members were selected based on meeting the requirements within the Terms of Reference. The membership of the Working Group has been listed on the Committees page, and I thank Drs. Rosemary Mueller and Ryan Lamont for volunteering to serve as co-chairs. The working group is now actively meeting via teleconferences, and will continue updates to the membership going forward.
|2019 Call for Nominations|
The Canadian College of Medical Geneticists (CCMG) is seeking interested members to serve as Directors on the Board. The Directors shall hold office from termination of the meeting at which they have been elected until their successors shall have been elected, for a maximum of four (4) years generally, unless they serve as officers.
Nominations are being solicited for 1 director, preferentially from a province other than Ontario, and with a cytogenetic or a biochemical laboratory specialty. However, nominations of all laboratory specialties are welcome.
Qualifications for Nominations:
Responsibilities include but are not limited to:
If you would like to nominate a CCMG member for consideration (or would like to be considered for a position yourself), please provide a brief statement on why you believe the nominee would be a good fit for the Board of Directors. The nominee will need to submit a short CV as well. Nomination submissions must be received no later than December 14, 2018.
Thank you for your time and consideration.
CCMG Awards and Nominations Committee
Hélène Bruyère, Chair
|Inaugural Applied Molecular Pathology Course|
In co-operation with the Ontario Molecular Pathology Research Network (OMPRN), the Canadian Association of Pathologists (CAP-ACP) and the Royal College of Physicians and Surgeons of Canada (RCPSC), CCMG is excited to announce the launching of the inaugural Applied Molecular Pathology Course!
The Course in Applied Molecular Pathology addresses the application of molecular concepts and techniques in the practice of contemporary diagnostic cancer pathology. The course uses hereditary colon cancer, lung cancer and diffuse large B-cell lymphoma as exemplars. Each of these tumour types is the focus of a half-day session led by a pathology subspecialist and a molecular diagnostics clinical scientist with supporting on-line material on basic genetic concepts and genetic laboratory techniques. The course is case-based, highly interactive and builds on fundamental molecular / genomics concepts to highlight the clinicopathological indications, application, interpretation and trouble-shooting of commonly used molecular assays.
After attending this course, participants will be able to:
This course will be of interest to residents and trainees as well as practicing pathologists, laboratory geneticists, pathologists’ assistants and others.
We hope to see you there.
|Save the Date - CCMG 2019 Annual Meeting, Niagara Falls|
The 43rd Annual Scientific Meeting in Niagara Falls, ON - June 22-26, 2019 - Sheraton on the Falls partnered with the Canadian Association of Pathologists (CAP-ACP), will be held at the Sheraton on the Falls in Niagara Falls, ON.
If you’re looking for a memorable conference to one of the world’s most celebrated landmarks, Sheraton On The Falls is one of the most adored Niagara Falls hotels for visitors from around the globe. From award-winning Niagara Falls view accommodations, to world-class dining and entertainment, to a convenient location that’s close to everything you’ll want to visit in Niagara Falls, hotels in Niagara Falls don’t get better than Sheraton On The Falls.
One of the signature features of the Sheraton Niagara Falls is their large selection of Fallsview Rooms, which comprise more than half of the hotel. Quickly walk indoors from Sheraton Niagara Falls to Casino Niagara and all Falls Avenue hotels, attractions, and restaurants. Splash around at the Fallsview Indoor Waterpark, have live animal encounters at the Rainforest Café, catch a 4-D movie, or more on Falls Avenue Resort.
The CCMG scientific conference is the largest gathering of healthcare professionals, trainees and decision-makers, with a focus on medical genetics, in Canada. Featuring high-profile keynote speakers; cutting-edge panels on current issues in genetics; and a wealth of networking activities, the conference is the country’s premier event for evidence-informed discussion and debate on health care. The 43rd Annual Scientific Meeting will feature a multi-disciplinary scientific program, renowned guest speakers, an extensive two-day trade show, and a great social program.
The CCMG Annual Meeting attendees include: Scientists/Researchers, Laboratory geneticists, directors, technicians, and technologists, Educators, Medical and clinical geneticists, Physicians of all specialties with an interest in genetics, genomics, and the genetic basis of disease, Genetic counselors, Nurses, Biotechnology and pharmaceutical development professionals, Fellows, trainees, and students
MAINTENANCE OF CERTIFICATION
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This activity was approved by the Canadian Association of Physical Medicine and Rehabilitation.
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.